 WASHINGTON (Reuters) - U.S. Food and Drug Administration  staff reviewers on Tuesday questioned clinical data for  non-Hodgkin's lymphoma drug Marqibo, made by Inex  Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc..